penicillamine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Yaşar, S | 1 |
| Gülbaş, Z | 1 |
| Ferry-Dumazet, H | 1 |
| Mamani-Matsuda, M | 1 |
| Dupouy, M | 1 |
| Belloc, F | 1 |
| Thiolat, D | 1 |
| Marit, G | 1 |
| Arock, M | 1 |
| Reiffers, J | 1 |
| Mossalayi, MD | 1 |
2 other studies available for penicillamine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases?
Topics: Antirheumatic Agents; CREST Syndrome; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positi | 2006 |
Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron.
Topics: Apoptosis; Cell Cycle; Cell Division; Cells, Cultured; Ferricyanides; Fusion Proteins, bcr-abl; Huma | 2002 |